CSPC INNOVATION PHARMACEUTICAL CO., LTD.

CSPC Innovation Pharmaceutical Co., Ltd.

300765

CNE100003K04

Food Processing

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-29 pm EDT			5-day change	1st Jan Change
30.36 ^CNY	-0.10%		-1.94%	-0.51%

Apr. 22	CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	China's drugmakers can't sell mRNA shots but haven't quit yet	RE

CSPC Innovation Pharmaceutical Co., Ltd. Approves Board Appointments

April 10, 2023 at 03:38 pm EDT

CSPC Innovation Pharmaceutical Co., Ltd. held its Annual General Meeting of 2022 on 07 April 2023, approved the Election of non-independent directors: Pan Weidong; Wang Huaiyu; CAI LEI; Han Feng; Yao Bing; Yang Dong. Election of independent directors: Li Dibin; Yang Peng; Di Congzhi. Election of non-employee supervisors: Zhang Jiyong; Zhang Ling.

Latest news about CSPC Innovation Pharmaceutical Co., Ltd.

CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22	CI
China's drugmakers can't sell mRNA shots but haven't quit yet	Apr. 19	RE
CSPC Innovation Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023	Apr. 09	CI
Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	Apr. 01	CI
CSPC Innovation Pharmaceutical Co., Ltd.(XSEC:300765) added to FTSE All-World Index	Mar. 17	CI
CSPC Innovation Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023	Mar. 15	CI
CSPC Innovation Pharmaceutical's Attributable Profit Rises 4%; Shares Jump 6%	Mar. 15	MT
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
CSPC Baike's 2023 Profit Reaches 859 Million Yuan	Jan. 25	MT
CSPC Innovation Pharmaceutical Co., Ltd. announced a financing transaction	Jan. 22	CI
Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	Jan. 03	CI
CSPC Innovation Pharmaceutical Co., Ltd.(SZSE:300765) added to Shenzhen Stock Exchange Component A Share Index	Dec. 12	CI
CSPC Innovation Pharmaceutical Co., Ltd.(SZSE:300765) added to Shenzhen Stock Exchange Component Index	Dec. 12	CI
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	23-10-11	CI
CSPC Innovation Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 421.8 million worth of its shares.	23-09-21	CI
CSPC Innovation Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	23-09-19	CI
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
China’s NMPA Accepts CSPC Pharma’s License Application for Asthma Drug	23-06-27	MT
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Cspc Innovation Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on April 27, 2023	23-04-20	CI
CSPC Innovation Pharmaceutical Co., Ltd. Approves Cash Dividend for 2022	23-04-10	CI
CSPC Innovation Pharmaceutical Co., Ltd. Approves Board Appointments	23-04-10	CI
CSPC Innovation Pharmaceutical Co., Ltd. Proposes Final Dividend for 2022	23-03-17	CI
CSPC Shengxue Glucose Co.,Ltd. announced that it expects to receive CNY 260 million in funding from CSPC Innovation Pharmaceutical Co., Ltd.	23-03-14	CI

Chart CSPC Innovation Pharmaceutical Co., Ltd.

Duration

Period

Chart CSPC Innovation Pharmaceutical Co., Ltd.

More charts

Company Profile

CSPC Innovation Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of functional ingredients. The Company operates two segments. Functional Ingredients segment mainly provides caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, theophylline, theobromine, pentoxifylline, doxofylline, and biological enzymes. Health Food Products segment mainly provides Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, and others. The Company mainly conducts businesses within the domestic market.

Sector

Food Processing

Calendar

2024-08-15 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for CSPC Innovation Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

30.36 CNY

Average target price

40.1 CNY

Spread / Average Target

+32.07%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-0.51%	5.89B
ZHEJIANG NHU COMPANY LTD.	+11.32%	8.01B
BELLRING BRANDS, INC.	+5.29%	7.48B
THE SIMPLY GOOD FOODS COMPANY	-4.90%	3.76B
BYHEALTH CO., LTD	-11.22%	3.55B
XIAMEN KINGDOMWAY GROUP COMPANY	-8.27%	1.26B
HERBALIFE LTD.	-33.22%	1.02B
SIRIO PHARMA CO., LTD.	+12.12%	967M
USANA HEALTH SCIENCES, INC.	-12.82%	890M
JAMIESON WELLNESS INC.	-17.02%	799M

Special Foods & Wellbeing Products